EARNEST Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $151M | Sell |
|
|||||
2025
Q1 | $151M | Buy |
|
|||||
2024
Q4 | $181M | Buy |
|
|||||
2024
Q3 | $193M | Sell |
|
|||||
2024
Q2 | $208M | Buy |
|
|||||
2024
Q1 | $242M | Buy |
|
|||||
2023
Q4 | $210M | Buy |
|
|||||
2023
Q3 | $158M | Buy |
|
|||||
2023
Q2 | $161M | Buy |
|
|||||
2023
Q1 | $115M | Buy |
|
|||||
2022
Q4 | $104M | Buy |
|
|||||
2022
Q3 | $91.2M | Buy |
|
|||||
2022
Q2 | $37.5M | Sell |
|
|||||
2022
Q1 | $50.3M | Sell |
|
|||||
2021
Q4 | $67M | Sell |
|
|||||
2021
Q3 | $77.1M | Sell |
|
|||||
2021
Q2 | $77.9M | Sell |
|
|||||
2021
Q1 | $63.8M | Sell |
|
|||||
2020
Q4 | $66.5M | Sell |
|
|||||
2020
Q3 | $62.8M | Sell |
|
|||||
2020
Q2 | $57.2M | Buy |
|
|||||
2020
Q1 | $41.4M | Buy |
|
|||||
2019
Q4 | $41.7M | Buy |
|
|||||
2019
Q3 | $31.9M | Buy |
|
|||||
2019
Q2 | $34.2M | Sell |
|
|||||
2019
Q1 | $35M | Buy |
|
|||||
2018
Q4 | $27.2M | Sell |
|
|||||
2018
Q3 | $32.5M | Sell |
|
|||||
2018
Q2 | $27.7M | Sell |
|
|||||
2018
Q1 | $26.8M | Buy |
|
|||||
2017
Q4 | $26.6M | Sell |
|
|||||
2017
Q3 | $28.3M | Buy |
|
|||||
2017
Q2 | $24.4M | Buy |
|
|||||
2017
Q1 | $20M | Buy |
|
|||||
2016
Q4 | $0 | Buy |
|